Relmada Therapeutics, Inc. (RLMD)
7.03
+0.69
(+10.88%)
USD |
NASDAQ |
May 19, 16:00
7.035
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Total Assets (Quarterly) : 235.36M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 472.31M |
| AN2 Therapeutics, Inc. | 87.49M |
| Corcept Therapeutics, Inc. | 814.88M |
| Assertio Holdings, Inc. | 211.30M |
| Johnson & Johnson | 200.89B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.63M |
| Shareholders Equity (Quarterly) | 218.73M |
| Current Ratio | 18.26 |